4.2 Editorial Material

Potential of CD73 as a target for cancer immunotherapy

Related references

Note: Only part of the references are listed.
Review Immunology

CD73: an emerging checkpoint for cancer immunotherapy

Siqi Chen et al.

IMMUNOTHERAPY (2019)

Review Pharmacology & Pharmacy

CD73 as a potential opportunity for cancer immunotherapy

Ghasem Ghalamfarsa et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2019)

Review Cell Biology

Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer

Mohammad H. Kazemi et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2018)

Article Cell Biology

Anti-angiogenic effects of CD73-specific siRNA-loaded nanoparticles in breast cancer-bearing mice

Ghasem Ghalamfarsa et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2018)

Review Immunology

Nanoparticles and targeted drug delivery in cancer therapy

Behdokht Bahrami et al.

IMMUNOLOGY LETTERS (2017)

Review Oncology

Targeting immunosuppressive adenosine in cancer

D. Vijayan et al.

NATURE REVIEWS CANCER (2017)

Article Oncology

CD73-Deficient Mice Are Resistant to Carcinogenesis

John Stagg et al.

CANCER RESEARCH (2012)

Article Anatomy & Morphology

CD73 Expression as a Potential Marker of Good Prognosis in Breast Carcinoma

Anna Supernat et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2012)

Article Medicine, General & Internal

NT5E Mutations and Arterial Calcifications

Cynthia St Hilaire et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Review Biochemistry & Molecular Biology

Extracellular adenosine triphosphate and adenosine in cancer

J. Stagg et al.

ONCOGENE (2010)

Article Multidisciplinary Sciences

Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

John Stagg et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Review Biotechnology & Applied Microbiology

Adenosine receptors:: therapeutic aspects for inflammatory and immune diseases

Gyorgy Hasko et al.

NATURE REVIEWS DRUG DISCOVERY (2008)